https://wikem.org/w/index.php?action=history&feed=atom&title=Venlafaxine 2026-04-18T19:57:01Z Revision history for this page on the wiki MediaWiki 1.38.2 https://wikem.org/w/index.php?title=Venlafaxine&diff=229787&oldid=prev 2019-09-23T23:26:55Z

<p><span dir="auto"><span class="autocomment">References</span></span></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="es"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Revisión anterior</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revisión del 23:26 23 sep 2019</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l61">Línea 61:</td> <td colspan="2" class="diff-lineno">Línea 61:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Pharmacology]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Pharmacology]]</div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">[[Category:Psychiatry]]</ins></div></td></tr> </table>

ClaireLewis https://wikem.org/w/index.php?title=Venlafaxine&diff=198158&oldid=prev 2018-11-04T17:30:10Z

<p><span dir="auto"><span class="autocomment">Adverse Reactions</span></span></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="es"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Revisión anterior</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revisión del 17:30 4 nov 2018</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l21">Línea 21:</td> <td colspan="2" class="diff-lineno">Línea 21:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Allergy to class/drug</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Allergy to class/drug</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*MAOI use concomitantly or within past 14 days</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*MAOI use concomitantly or within past 14 days</div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">==Toxicity&lt;ref>Whyte IM et al. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. QJM: An International Journal of Medicine, Volume 96, Issue 5, 1 May 2003, Pages 369–374.&lt;/ref>==</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">*Sodium channel blocking properties, similar to [[TCA toxicity]] and should be treated similarly:</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">**Sodium bicarbonate for QRS prolongation</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">**Benzodiazepines for seizures</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">*QTc prolongation</ins></div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Adverse Reactions==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Adverse Reactions==</div></td></tr> </table>

Kxl328 https://wikem.org/w/index.php?title=Venlafaxine&diff=128911&oldid=prev 2017-03-28T18:48:51Z

<p>Created page with &quot;==Administration== *Type: SNRI *Dosage Forms: *Routes of Administration: Oral *Common Trade Names: Effexor ==Adult Dosing== *Extended release: 37.5-225mg PO daily *Immediate...&quot;</p> <p><b>Página nueva</b></p><div>==Administration==<br /> *Type: SNRI<br /> *Dosage Forms:<br /> *Routes of Administration: Oral<br /> *Common Trade Names: Effexor<br /> <br /> ==Adult Dosing==<br /> *Extended release: 37.5-225mg PO daily<br /> *Immediate release: 75-375mg PO daily in 2-3 divided doses<br /> <br /> ==Pediatric Dosing==<br /> ''Safety/efficacy not established''<br /> <br /> ==Special Populations==<br /> *[[Drug pregnancy categories|Pregnancy Rating]]: C<br /> *Lactation risk: Infant risk cannot be ruled out<br /> *Renal dosing: decrease dose by 25-50%<br /> *Hepatic dosing: decrease dose by 25-50%<br /> <br /> ==Contraindications==<br /> *Allergy to class/drug<br /> *MAOI use concomitantly or within past 14 days<br /> <br /> ==Adverse Reactions==<br /> ===Serious===<br /> *Seizure<br /> *Neuroleptic malignant syndrome, serotonin syndrome<br /> *GI bleed<br /> *Hepatitis<br /> *Hyponatremia<br /> *Exacerbation of depression, suicidality, mania<br /> ===Common===<br /> *Constipation, nausea, xerostomia, anorexia, weight loss<br /> *Dizziness, insomnia, somnolence, dream disorder, tremor, anxiety, blurred vision<br /> *Sweating<br /> *Hypertension<br /> *Sexual dysfunction<br /> <br /> ==Pharmacology==<br /> *Half-life: 5-11h<br /> *Metabolism: Hepatic, CYP2D6<br /> *Excretion: Mostly renal<br /> <br /> ==Mechanism of Action==<br /> *Inhibits serotonin, norepinephrine and dopamine reuptake<br /> <br /> ==Comments==<br /> <br /> <br /> ==See Also==<br /> *[[SNRI Toxicity]]<br /> <br /> ==References==<br /> &lt;references/&gt;<br /> <br /> [[Category:Pharmacology]]</div>

ClaireLewis